At the forefront of therapies for rare and orphan diseasesTM
HOME CONTACT US         
Share
about us| programs| science & technology | patient advocacy | clinical studies | investors | collaborations | news & events
 
Investors
 



Home >> Investor Relations >> Corporate Governance >> Insider Transactions

Insider Transactions

Date Name Title Type Shares Traded Sorted Ascending Price Range
Jun 17, 2008 patterson matthew r Officer Automatic Sell 1,800 11.00 - 11.20
Jul 23, 2008 bloch stephen m Director Automatic Sell 1,834 15.00
Jul 16, 2008 bloch stephen m Director Automatic Sell 1,900 13.16
Feb 26, 2008 fhm iv lp Beneficial Owner (10% or more) Buy 1,900 9.99 - 10.28
Feb 26, 2008 topper james n Director Buy 1,900 9.99 - 10.28
Feb 11, 2009 bloch stephen m Director Sell 1,908 9.42
Oct 31, 2008 patterson matthew r Officer Automatic Sell 1,939 10.00
Feb 22, 2008 fhm iv lp Beneficial Owner (10% or more) Buy 2,000 9.53 - 9.66
Aug 20, 2008 patterson matthew r Officer Automatic Sell 2,000 13.54
Oct 20, 2008 patterson matthew r Officer Automatic Sell 2,000 10.73 - 11.51
Feb 22, 2008 topper james n Director Buy 2,000 9.53 - 9.66
Feb 28, 2008 fhm iv lp Beneficial Owner (10% or more) Buy 2,038 9.84 - 9.96
Feb 28, 2008 topper james n Director Buy 2,038 9.84 - 9.96
Jul 7, 2008 crowley john f Officer Automatic Sell 2,200 10.69 - 11.26
Oct 31, 2008 palling david Officer Automatic Sell 2,200 10.00
May 24, 2011 valenzano ken Officer Sell 2,250 7.50
May 24, 2011 valenzano ken Officer Option Execute 2,250 0.64
Jul 25, 2008 bloch stephen m Director Automatic Sell 2,300 15.43
Oct 6, 2008 crowley john f Officer Automatic Sell 2,300 14.75 - 14.76
Apr 1, 2008 crowley john f Officer Automatic Sell 2,400 10.83 - 11.29
Showing 81-100 of 392 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Amicus Therapeutics, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.


Copyright © 2012 Amicus Therapeutics, Inc. All rights reserved.   Terms of Use | Privacy Policy